# Gilead Sciences
Who / What
Gilead Sciences is an American biopharmaceutical company. It focuses on researching and developing antiviral drugs for diseases including HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.
Background & History
The company was founded in 1987 and is headquartered in Foster City, California. It originally focused on antiviral therapeutics and has since become a significant player in the pharmaceutical industry. Key milestones include the development of major antiviral drugs such as ledipasvir/sofosbuvir and sofosbuvir.
Why Notable
Gilead Sciences is notable for its substantial contributions to antiviral medicine, particularly in the treatment of life-threatening viral infections like HIV and hepatitis C. The company's products have had a significant global health impact, improving treatment standards. Its inclusion in major stock indices like the Nasdaq-100 and S&P 100 underscores its importance in the biopharmaceutical sector.
In the News
Gilead remains relevant due to its ongoing research and development efforts, especially concerning treatments for COVID-19. Recent developments in its antiviral portfolio continue to draw public and investor attention. The company's work is critical in addressing current and emerging global health challenges.
